These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6684645)

  • 1. Dapsone levels after oral therapy and weekly oily injections in Ethiopian leprosy patients.
    Modderman ES; Merkus FW; Zuidema J; Hilbers HW; Warndorff T
    Int J Lepr Other Mycobact Dis; 1983 Jun; 51(2):191-6. PubMed ID: 6684645
    [No Abstract]   [Full Text] [Related]  

  • 2. Sex differences in the absorption of dapsone after intramuscular injection.
    Modderman ES; Merkus FW; Zuidema J; Hilbers HW; Warndorff T
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):359-65. PubMed ID: 6685698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oily injections of dapsone; an acceptable form of treatment?
    Warndorff van Diepen T
    Lepr Rev; 1986 Mar; 57(1):70-2. PubMed ID: 3702583
    [No Abstract]   [Full Text] [Related]  

  • 4. Dapsone in wheat flour as a possible method of therapy in leprosy. A laboratory report.
    Naik SS; Pandya SS
    Lepr India; 1977 Oct; 49(4):516-20. PubMed ID: 604659
    [No Abstract]   [Full Text] [Related]  

  • 5. Intramuscular injection of dapsone in therapy for leprosy: a new approach.
    Modderman ES; Huikeshoven H; Zuidema J; Leiker DL; Merkus FW
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):51-6. PubMed ID: 7061179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring the regularity of self administration of dapsone by leprosy patients.
    Kumar A; Balakrishnan S
    Lepr India; 1982 Oct; 54(4):664-70. PubMed ID: 7183832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rifampin 1200 mg once monthly together with daily Lamprene and dapsone in treatment of refactory patients with lepromatous leprosy.
    Paul S; Rose ET
    Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):342-3. PubMed ID: 7198625
    [No Abstract]   [Full Text] [Related]  

  • 8. Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal.
    Pandey B; Shrestha K; Lewis J; Hawksworth RA; Walker SL
    Trop Doct; 2007 Jul; 37(3):162-3. PubMed ID: 17716505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral zinc as an adjunct to dapsone in lepromatous leprosy.
    Mathur NK; Bumb RA; Mangal HN; Sharma ML
    Int J Lepr Other Mycobact Dis; 1984 Sep; 52(3):331-8. PubMed ID: 6541200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of DDS therapy on the acetylcholine sweat function test in fifty cases of tuberculoid and maculoanesthetic leprosy.
    Yawalkar SJ; Sanjana HB
    Int J Lepr Other Mycobact Dis; 1974; 42(1):55-7. PubMed ID: 4472091
    [No Abstract]   [Full Text] [Related]  

  • 11. Unusual reaction to intramuscular sulfone in two leprosy patients in Malaysia.
    Laing AB
    Int J Lepr Other Mycobact Dis; 1980 Mar; 48(1):70. PubMed ID: 7189187
    [No Abstract]   [Full Text] [Related]  

  • 12. Prothionamide and dapsone therapy in leprosy--a clinical study.
    Kundu SK; Hazra SK; Chaudhury SK; Chatterjee B
    Indian J Lepr; 1985; 57(1):90-6. PubMed ID: 3839829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of leprosy with sulfonamides. Emphasis on the use of weekly doses.
    Opromolla DV
    Int J Lepr Other Mycobact Dis; 1971; 39(2):467-70. PubMed ID: 4948085
    [No Abstract]   [Full Text] [Related]  

  • 14. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapeutic trials in leprosy. 4. Dapsone (DDS) in low dosage in the treatment of lepromatous leprosy. A demonstration pilot study.
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(2):140-8. PubMed ID: 5338958
    [No Abstract]   [Full Text] [Related]  

  • 16. [Vitamin E as protective agent against hemolysis in leprosy patients under dapsone treatment].
    Lardo MM; Díaz NB; Artaza JR; Carbia CD; Nazer R; Valdez R
    Medicina (B Aires); 1997; 57(2):150-4. PubMed ID: 9532824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing the level of dapsone in blood.
    Beiguelman B; Pinto W; El-Guindy MM; Krieger H
    Bull World Health Organ; 1974; 51(5):467-71. PubMed ID: 4549497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clofazimine and dapsone--a combination therapy in erythema nodosum leprosum syndrome.
    Dutta RK
    Lepr India; 1980 Apr; 52(2):252-9. PubMed ID: 7453140
    [No Abstract]   [Full Text] [Related]  

  • 19. Dapsone haemolysis in leprosy. A preliminary report.
    Menezes S; Rege VL; Sehgal VN
    Lepr India; 1981 Jan; 53(1):63-9. PubMed ID: 7218764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Operational study to monitor the regularity of dapsone intake by leprosy out-patients.
    Kumar A; Balakrishnan S
    Lepr India; 1983 Jul; 55(3):521-7. PubMed ID: 6656209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.